A detailed history of Mjp Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Mjp Associates Inc holds 5,832 shares of NVO stock, worth $609,793. This represents 0.13% of its overall portfolio holdings.

Number of Shares
5,832
Previous 4,863 19.93%
Holding current value
$609,793
Previous $694,000 -0.0%
% of portfolio
0.13%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $115,378 - $140,911
969 Added 19.93%
5,832 $694,000
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $48,838 - $58,470
398 Added 8.91%
4,863 $694,000
Q1 2024

Apr 11, 2024

BUY
$102.11 - $135.92 $59,530 - $79,241
583 Added 15.02%
4,465 $573,000
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $6,759 - $8,119
77 Added 2.02%
3,882 $401,000
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $346,026 - $759,249
3,805 New
3,805 $346,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mjp Associates Inc Portfolio

Follow Mjp Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mjp Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mjp Associates Inc with notifications on news.